• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICROPORT ORTHOPEDICS INC. ORTHOSET I BONE CEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICROPORT ORTHOPEDICS INC. ORTHOSET I BONE CEMENT Back to Search Results
Model Number 14101000
Medical Device Problem Code Material Deformation (2976)
Health Effect - Clinical Code No Known Impact Or Consequence To Patient (2692)
Type of Reportable Event Malfunction
Event or Problem Description
Allegedly, bone cement was damaged.
 
Additional Manufacturer Narrative
Not known serious injury as a result of this incident.Please void the initial report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORTHOSET I BONE CEMENT
Common Device Name
BONE CEMENT
Manufacturer (Section D)
MICROPORT ORTHOPEDICS INC.
5677 airline rd.
arlington TN 38002
MDR Report Key10340625
Report Number3010536692-2020-00528
Device Sequence Number1865600
Product Code LOD
UDI-Device IdentifierM684141010001
UDI-PublicM684141010001
Combination Product (Y/N)N
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source distributor
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 11/16/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Other
Device Model Number14101000
Device Catalogue Number14101000
Device Lot Number19W115
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Distributor Facility Aware Date07/08/2020
Initial Date Received by Manufacturer 07/08/2020
Supplement Date Received by Manufacturer07/08/2020
Initial Report FDA Received Date07/29/2020
Supplement Report FDA Received Date11/16/2020
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
-
-